IRulya Therapeutics IRLA
NASDAQ IRLA
$33.78 +2.78 (+8.95%)
At close: Nov 9, 2026 · 4:00 PM EST

IRulya Therapeutics (IRLA) Other Operating Expenses (2022 - 2026)

Updated

IRulya Therapeutics (IRLA) reported Other Operating Expenses of $62.36 million for Q2 2026, up 931.2% from $6.05 million a year earlier and up 593.8% from the prior quarter.

Analysis

IRulya Therapeutics (IRLA) Other Operating Expenses (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, IRulya Therapeutics' Other Operating Expenses came in at $94.95 million, up 329.1% year-over-year; for FY2025, it was $37.99 million, up 10.2% from FY2024.

  • Other Operating Expenses has a five-year compound annual growth rate of -9.1% (FY2020 to FY2025).
  • By year, Other Operating Expenses came in at $34.49 million in FY2024 (+103.8%), $16.93 million in FY2023 (-34.9%), $26 million in FY2022 (-57.2%) and $60.8 million in FY2021 (-0.8%).
  • The Q2 2026 figure ranks as the highest quarterly Other Operating Expenses in data going back to Q1 2018.
  • Year over year, Other Operating Expenses has now increased in each of the last four quarters, with growth averaging 220.9% over the last eight quarters.
  • The high point for year-over-year Other Operating Expenses in five years was Q2 2026 (growth of 931.2%); the low point was Q3 2022 (a decline of 76.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $8.99 million (Q1 2026), $14.56 million (Q4 2025) and $9.05 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 IRulya Therapeutics 207.35 Mn 91.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -64.33 Mn
Dec 31, 2025 3.12 Mn
Sep 30, 2025 2.10 Mn
Jun 30, 2025 532,000.00
Mar 31, 2025 1.92 Mn
Dec 31, 2024 1.90 Mn
Sep 30, 2024 -2.68 Mn
Jun 30, 2024 2.22 Mn
Mar 31, 2024 2.55 Mn
Dec 31, 2023 1.58 Mn
Mar 31, 2023 5.90 Mn
Sep 30, 2022 825,000.00
API Access

IRulya Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=IRLA&period=max&api_key=YOUR_API_KEY